Almitrine bismesylate, also known simply as almitrine, is a medication used to treat chronic obstructive pulmonary disease (COPD), a lung condition that makes it difficult to breathe. It works by stimulating the chemoreceptors in the carotid bodies, which are located in the neck near the carotid arteries. These chemoreceptors are responsible for sensing changes in blood oxygen and carbon dioxide levels. When almitrine stimulates these chemoreceptors, it tells the brain to increase breathing rate and depth, which can help to improve oxygen levels in the blood.
Almitrine bismesylate is available in tablet form and is typically taken three times a day. The most common side effects of almitrine are headache, dizziness, and nausea. It is important to note that almitrine is not a cure for COPD, but it can help to improve symptoms and make it easier to breathe.
It is important to speak to a doctor before taking almitrine bismesylate, as it can interact with other medications. Almitrine is not suitable for everyone, and people with certain medical conditions, such as heart disease or high blood pressure, may not be able to take it.
Here are some additional points to note about almitrine bismesylate:
- It is not widely available and is not approved for use in the United States.
- It is considered an investigational drug, meaning that more research is needed to confirm its long-term safety and efficacy.
- There is some evidence that it may be effective in improving symptoms of COPD, but more research is needed.